Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FerGene’s phase 3 NMIBC study of Nadofaragene Firadenovec meets primary endpoint
FerGene’s phase 3 NMIBC study of Nadofaragene Firadenovec meets primary endpoint. Photo: courtesy of PublicDomainPictures from Pixabay.
FerGene’s phase 3 NMIBC study of Nadofaragene Firadenovec meets primary endpoint. Photo: courtesy of PublicDomainPictures from Pixabay.